S2 Ep4: A Biotech Mindset & The Drive to Discover Targeted Cancer Treatments
The promise of science to change people’s lives has never been greater. Recent progress in understanding biology, including the sequencing of the human genome, has led to new insights — allowing scientists more power and precision to treat disease, including cancer. As the understanding of cancer grows, scientists have found that it’s actually not a single disease but a collection of diseases that are driven by various causes or genetic breakdowns. Joe talks to Pete Nicholas, co-founder of Boston Scientific about his diagnosis of a very aggressive form of non-small cell lung cancer. Joe also talks to Anne White, President of Lilly Oncology, about the factors that came into play to redesign a traditional oncology research and development organization into a biotech and how this new mindset has the potential to develop more medicines for people living with cancer.